AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 214 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,462,374 | -29.8% | 261,106 | -19.7% | 0.00% | -33.3% |
| Q2 2023 | $9,210,259 | +31.2% | 325,221 | +6.4% | 0.00% | +50.0% |
| Q1 2023 | $7,022,250 | +5.1% | 305,714 | +28.4% | 0.00% | 0.0% |
| Q4 2022 | $6,684,000 | +47.6% | 238,009 | +48.7% | 0.00% | 0.0% |
| Q3 2022 | $4,527,000 | +77.7% | 160,077 | +190.1% | 0.00% | +100.0% |
| Q3 2021 | $2,547,000 | -53.2% | 55,185 | -44.1% | 0.00% | -50.0% |
| Q2 2021 | $5,438,000 | +93.1% | 98,671 | +81.0% | 0.00% | +100.0% |
| Q1 2021 | $2,816,000 | +39.8% | 54,525 | +17.2% | 0.00% | 0.0% |
| Q4 2020 | $2,015,000 | -13.3% | 46,512 | -30.0% | 0.00% | 0.0% |
| Q3 2020 | $2,325,000 | +902.2% | 66,429 | +1429.9% | 0.00% | – |
| Q2 2020 | $232,000 | -94.7% | 4,342 | -96.5% | 0.00% | -100.0% |
| Q1 2020 | $4,344,000 | -91.6% | 122,410 | -88.7% | 0.00% | -90.9% |
| Q4 2019 | $51,898,000 | +23.5% | 1,086,848 | -16.2% | 0.02% | +15.8% |
| Q3 2019 | $42,011,000 | -23.3% | 1,296,624 | +18.1% | 0.02% | -24.0% |
| Q2 2019 | $54,768,000 | +28.1% | 1,098,002 | +73.2% | 0.02% | +25.0% |
| Q1 2019 | $42,749,000 | +43.2% | 633,879 | -2.1% | 0.02% | +33.3% |
| Q4 2018 | $29,860,000 | -21.6% | 647,585 | +31.2% | 0.02% | +15.4% |
| Q3 2018 | $38,069,000 | +40.6% | 493,641 | +53.5% | 0.01% | +8.3% |
| Q2 2018 | $27,085,000 | -33.6% | 321,550 | -35.5% | 0.01% | -33.3% |
| Q1 2018 | $40,760,000 | +1205.6% | 498,421 | +814.8% | 0.02% | +1700.0% |
| Q4 2017 | $3,122,000 | -18.7% | 54,487 | -5.2% | 0.00% | -50.0% |
| Q3 2017 | $3,838,000 | +49.2% | 57,504 | +15.0% | 0.00% | +100.0% |
| Q2 2017 | $2,572,000 | +7.3% | 49,994 | +21.9% | 0.00% | 0.0% |
| Q1 2017 | $2,397,000 | +51.9% | 41,029 | +8.5% | 0.00% | 0.0% |
| Q4 2016 | $1,578,000 | -2.5% | 37,814 | +23.3% | 0.00% | 0.0% |
| Q3 2016 | $1,619,000 | +75.4% | 30,657 | +39.2% | 0.00% | 0.0% |
| Q2 2016 | $923,000 | +19.4% | 22,029 | +15.7% | 0.00% | – |
| Q1 2016 | $773,000 | -26.9% | 19,046 | +17.0% | 0.00% | -100.0% |
| Q4 2015 | $1,057,000 | +50.4% | 16,275 | +63.4% | 0.00% | – |
| Q3 2015 | $703,000 | -41.1% | 9,958 | -7.3% | 0.00% | -100.0% |
| Q2 2015 | $1,193,000 | +106.4% | 10,738 | +75.4% | 0.00% | – |
| Q1 2015 | $578,000 | -55.7% | 6,123 | -47.5% | 0.00% | -100.0% |
| Q4 2014 | $1,306,000 | -9.5% | 11,661 | -50.4% | 0.00% | 0.0% |
| Q3 2014 | $1,443,000 | -15.8% | 23,520 | -37.1% | 0.00% | 0.0% |
| Q2 2014 | $1,714,000 | +60.0% | 37,408 | +36.7% | 0.00% | 0.0% |
| Q1 2014 | $1,071,000 | – | 27,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |